Watch: Sun Pharma posts cons loss of Rs 425 crore in June quarter
Sun Pharmaceuticals, India’s largest drug maker, on Friday reported a consolidated loss of Rs 424.92 crore (after taxes, share of profit of associates and JVs) for the quarter ended June 30 on account of a one-time loss of Rs 950.50 crore on antitrust litigation related to a product Modafinil.
Other Results Videos
Maruti Suzuki Q3 Results: PAT jumps 33% YoY to Rs 3,207 cr; revenue up 15%
L&T Q3 Results: Net profit rises 16% YoY to Rs 2,947 cr; revenue up 19%
L&T Q3 results Preview: Here's what to expect from infrastructure major
Dr Reddy's Q3 Results: Profit meets estimates, jumps 11% YoY to Rs 1,379 cr; revenue up 7%
ITC Q3 Results: Profit rises 6% YoY to Rs 5,335 cr; co declares Rs 6.25/share dividend
